RankAlpha logo
Back to Rankings

HRMY

Harmony BiosciencesA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
HRMY vs peer average
80/100
HRMY vs. peer average (A vs. C)
Grade spread
A 2 · C 3 · D 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

BHVN is the first available peer comparator.

Same-sector, similar-market-cap comparator, but its development and commercial exposure differ materially from Harmony's WAKIX-centered rare-neurology franchise; read-through is limited.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerBHVNBiohaven
HRMY
Harmony Biosciences
BHVN
Biohaven
Grade
A
A
Momentum
75
75
Value
71
41
Sentiment
75
88
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs BHVN

HRMY / BHVN
Grade Position
Above peers
HRMY vs. peer average (A vs. C)
80/100
Momentum
75
HRMY
Value
71
HRMY
Sentiment
75
BHVN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs HRMY
1
BHVN
BHVN
A
100/100
Even
2
PVLA
PVLA
D
40/100
+3
3
ALMR
Alamar Biosciences Inc Common
C
60/100
+2
4
VCEL
Vericel Corp Common
C
60/100
+2
5
HCM
HUTCHMED (China) Ltd ADR
D
40/100
+3
BHVN is the first peer returned for this comparison set.